To define the cell populations that drive joint inflammation in rheumatoid arthritis (RA), we
applied single-cell RNA sequencing (scRNA-seq), mass cytometry, bulk RNA sequencing (…

Objective To establish in a global setting the relationships between countries’
socioeconomic status (SES), measured biological disease modifying antirheumatic drug (bDMARD)-…

Rheumatoid arthritis (RA) is a systemic inflammatory disease that affects approximately 1%
of the population worldwide. If undertreated, patients are at risk for joint destruction and …

Sjogren syndrome (SS) is a lymphocyte-mediated, infiltrative autoimmune disorder
characterized by destruction of exocrine glands. The glandular damage leads to secretory …

As very effective targeted biological therapies have become available to treat rheumatoid
arthritis (RA), remission is now the goal of treatment. Since 1981, efforts have been undertaken …

Objectives To compare consecutive disease modifying antirheumatic drug (DMARD)-treatment
regimes in daily practice in patients with rheumatoid arthritis (RA) who failed on initial …

Background Tumor necrosis factor alpha (TNFα) is a key cytokine in both the pathogenesis
of inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) and the host defense …

Objectives In RA, the relationship between autoantibody status and treatment response to
MTX remains unclear. We investigated the association between autoantibody status and early …

Objective To investigate associations between baseline presence of erosions and/or anti-citrullinated
protein antibodies (ACPA) on functional ability, disease activity and treatment …

Objective. To compare the association between different remission criteria and physical
function in patients with rheumatoid arthritis followed in clinical practice. Methods. Longitudinal …